• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology

    6/9/23 8:18:00 AM ET
    $ABC
    $TPG
    Other Pharmaceuticals
    Health Care
    Investment Managers
    Finance
    Get the next $ABC alert in real time by email

    TPG (NASDAQ:TPG), a global alternative asset management firm, and AmerisourceBergen Corporation (NYSE:ABC) today announced the completion of their previously announced acquisition of OneOncology, a network of leading oncology practices.

    TPG has acquired a majority interest in OneOncology, and AmerisourceBergen has acquired a minority interest in the company. OneOncology's affiliated practices, physicians, and management team have also retained a minority interest in the company. The partnership provides OneOncology with additional resources to grow its platform and invest behind clinical, operational, and technical capabilities to continue to deliver high-quality, comprehensive patient care.

    About TPG

    TPG is a leading global alternative asset management firm, founded in San Francisco in 1992, with $137 billion of assets under management and investment and operational teams around the world. TPG invests across five multi-strategy platforms: Capital, Growth, Impact, Real Estate, and Market Solutions and our unique strategy is driven by collaboration, innovation, and inclusion. Our teams combine deep product and sector experience with broad capabilities and expertise to develop differentiated insights and add value for our fund investors, portfolio companies, management teams, and communities. For more information, visit www.tpg.com or on Twitter @TPG.

    About AmerisourceBergen

    AmerisourceBergen is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 44,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500 and #21 on the Global Fortune 500 with more than $200 billion in annual revenue.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230609005181/en/

    Get the next $ABC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABC
    $TPG

    CompanyDatePrice TargetRatingAnalyst
    TPG Inc.
    $TPG
    7/30/2025$69.00Neutral → Outperform
    BNP Paribas Exane
    TPG Inc.
    $TPG
    6/20/2025$60.00Outperform
    Wolfe Research
    TPG Inc.
    $TPG
    4/14/2025$47.00Overweight → Equal-Weight
    Morgan Stanley
    TPG Inc.
    $TPG
    9/12/2024$60.00Overweight
    Wells Fargo
    TPG Inc.
    $TPG
    5/10/2024$43.00 → $52.00Equal-Weight → Overweight
    Morgan Stanley
    TPG Inc.
    $TPG
    1/4/2024$38.00Market Perform
    TD Cowen
    TPG Inc.
    $TPG
    12/6/2023$36.00Market Perform
    BMO Capital Markets
    TPG Inc.
    $TPG
    11/30/2023$43.00Buy
    Goldman
    More analyst ratings

    $ABC
    $TPG
    SEC Filings

    View All

    SEC Form S-8 filed by TPG Inc.

    S-8 - TPG Inc. (0001880661) (Filer)

    3/11/24 4:53:30 PM ET
    $TPG
    Investment Managers
    Finance

    TPG Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Creation of a Direct Financial Obligation

    8-K - TPG Inc. (0001880661) (Filer)

    3/5/24 4:05:43 PM ET
    $TPG
    Investment Managers
    Finance

    SEC Form CERT filed by TPG Inc.

    CERT - TPG Inc. (0001880661) (Filer)

    3/4/24 5:20:16 PM ET
    $TPG
    Investment Managers
    Finance

    $ABC
    $TPG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Messemer Deborah M. sold $280,980 worth of shares (6,390 units at $43.97), decreasing direct ownership by 26% to 18,033 units (SEC Form 4)

    4 - TPG Inc. (0001880661) (Issuer)

    3/1/24 5:14:22 PM ET
    $TPG
    Investment Managers
    Finance

    Vazquez-Ubarri Anilu converted options into 101,937 shares and sold $4,244,657 worth of shares (101,937 units at $41.64) (SEC Form 4)

    4 - TPG Inc. (0001880661) (Issuer)

    2/29/24 7:23:41 PM ET
    $TPG
    Investment Managers
    Finance

    Winkelried Jon converted options into 1,000,000 shares and sold $43,757,311 worth of shares (1,050,848 units at $41.64) (SEC Form 4)

    4 - TPG Inc. (0001880661) (Issuer)

    2/29/24 7:01:19 PM ET
    $TPG
    Investment Managers
    Finance

    $ABC
    $TPG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors

    Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors NEW YORK, Sept. 25, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (NASDAQ: PAVM), today announced the appointment of accomplished healthcare executive John R. Palumbo to its Board of Directors, effective September 22, 2025. "John is a highly accomplished executive whose 40 years of healthcare leadership experience spans earl

    9/25/25 8:01:00 AM ET
    $LUCD
    $MDRX
    $PAVM
    Medical/Dental Instruments
    Health Care
    EDP Services
    Technology

    TPG RE Finance Trust, Inc. Announces Retirement of Chief Financial Officer Bob Foley and Appointment of Brandon Fox as Interim Chief Financial Officer

    TPG RE Finance Trust, Inc. (NYSE:TRTX) ("TRTX" or the "Company") today announced that Robert ("Bob") R. Foley, the Company's chief financial officer, has decided to retire from TPG at the end of the year. He will become a senior advisor to TPG's real estate credit business and transition his day-to-day duties to Brandon Fox, TRTX's chief accounting officer, who will assume the role of interim chief financial officer of TRTX, effective October 1, 2025. "On behalf of our board and entire team, I want to thank Bob for his leadership and unwavering commitment to TRTX. He has played a critical role in growing and expanding our business over the past ten years, and we wish him all the best in h

    9/15/25 4:15:00 PM ET
    $TPG
    $TRTX
    Investment Managers
    Finance
    Real Estate Investment Trusts
    Real Estate

    TPG RE Finance Trust, Inc. Declares Cash Dividend on Common Stock

    TPG RE Finance Trust, Inc. (NYSE:TRTX) ("TRTX" or the "Company") today announced that the Company's Board of Directors has declared a cash dividend of $0.24 per share of common stock for the third quarter of 2025. The dividend will be payable on October 24, 2025 to common stockholders of record as of September 26, 2025. ABOUT TRTX TRTX is a commercial real estate finance company that originates, acquires, and manages primarily first mortgage loans secured by institutional properties located in primary and select secondary markets in the United States. The Company is externally managed by TPG RE Finance Trust Management, L.P., a part of TPG Real Estate, which is the real estate investmen

    9/12/25 4:15:00 PM ET
    $TPG
    $TRTX
    Investment Managers
    Finance
    Real Estate Investment Trusts
    Real Estate

    $ABC
    $TPG
    Leadership Updates

    Live Leadership Updates

    View All

    Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors

    Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors NEW YORK, Sept. 25, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (NASDAQ: PAVM), today announced the appointment of accomplished healthcare executive John R. Palumbo to its Board of Directors, effective September 22, 2025. "John is a highly accomplished executive whose 40 years of healthcare leadership experience spans earl

    9/25/25 8:01:00 AM ET
    $LUCD
    $MDRX
    $PAVM
    Medical/Dental Instruments
    Health Care
    EDP Services
    Technology

    TPG RE Finance Trust, Inc. Announces Retirement of Chief Financial Officer Bob Foley and Appointment of Brandon Fox as Interim Chief Financial Officer

    TPG RE Finance Trust, Inc. (NYSE:TRTX) ("TRTX" or the "Company") today announced that Robert ("Bob") R. Foley, the Company's chief financial officer, has decided to retire from TPG at the end of the year. He will become a senior advisor to TPG's real estate credit business and transition his day-to-day duties to Brandon Fox, TRTX's chief accounting officer, who will assume the role of interim chief financial officer of TRTX, effective October 1, 2025. "On behalf of our board and entire team, I want to thank Bob for his leadership and unwavering commitment to TRTX. He has played a critical role in growing and expanding our business over the past ten years, and we wish him all the best in h

    9/15/25 4:15:00 PM ET
    $TPG
    $TRTX
    Investment Managers
    Finance
    Real Estate Investment Trusts
    Real Estate

    JD Vargas Joins TPG as Partner

    Vargas joins growing TPG Rise Climate Transition Infrastructure team TPG Inc. (NASDAQ:TPG), a leading global alternative investment firm, announced today the appointment of Juan Diego "JD" Vargas as a Partner, serving as a senior member of the TPG Rise Climate Transition Infrastructure ("TPG Rise Climate TI") team, effective today. Vargas will play a key role in expanding the firm's value-add infrastructure strategy, which focuses on growing and scaling businesses and assets in essential subsectors and geographies across the climate ecosystem. He is based in New York. Vargas brings to TPG nearly 20 years of experience investing in energy and infrastructure. Most recently, he served as a

    9/8/25 12:00:00 PM ET
    $TPG
    Investment Managers
    Finance

    $ABC
    $TPG
    Financials

    Live finance-specific insights

    View All

    TPG RE Finance Trust, Inc. Declares Cash Dividend on Common Stock

    TPG RE Finance Trust, Inc. (NYSE:TRTX) ("TRTX" or the "Company") today announced that the Company's Board of Directors has declared a cash dividend of $0.24 per share of common stock for the third quarter of 2025. The dividend will be payable on October 24, 2025 to common stockholders of record as of September 26, 2025. ABOUT TRTX TRTX is a commercial real estate finance company that originates, acquires, and manages primarily first mortgage loans secured by institutional properties located in primary and select secondary markets in the United States. The Company is externally managed by TPG RE Finance Trust Management, L.P., a part of TPG Real Estate, which is the real estate investmen

    9/12/25 4:15:00 PM ET
    $TPG
    $TRTX
    Investment Managers
    Finance
    Real Estate Investment Trusts
    Real Estate

    TPG RE Finance Trust, Inc. Declares Cash Dividend on Series C Cumulative Redeemable Preferred Stock

    TPG RE Finance Trust, Inc. (NYSE:TRTX) ("TRTX" or the "Company") today announced the Company's Board of Directors declared a cash dividend of $0.3906 per share of 6.25% Series C Cumulative Redeemable Preferred Stock (the "Series C Preferred Stock") for the third quarter of 2025. The Series C Preferred Stock dividend is payable on September 30, 2025 to preferred stockholders of record as of September 19, 2025. ABOUT TRTX TRTX is a commercial real estate finance company that originates, acquires, and manages primarily first mortgage loans secured by institutional properties located in primary and select secondary markets in the United States. The Company is externally managed by TPG RE Fi

    9/8/25 4:15:00 PM ET
    $TPG
    $TRTX
    Investment Managers
    Finance
    Real Estate Investment Trusts
    Real Estate

    TPG RE Finance Trust, Inc. Announces Share Repurchase Program

    TPG RE Finance Trust, Inc. (NYSE:TRTX) ("TRTX" or the "Company") today announced that the Company's board of directors has approved a new share repurchase program (the "Program") pursuant to which the Company is authorized to repurchase up to $25.0 million of the Company's common stock. The Program authorizes the repurchase of common stock from time to time on the open market or in privately negotiated transactions, including under 10b5-1 plans. The Program succeeds to a previously-authorized $25.0 million program, the remaining capacity of which was fully utilized during the third quarter of 2025. ABOUT TRTX TPG RE Finance Trust, Inc. is a commercial real estate finance company that or

    9/4/25 4:15:00 PM ET
    $TPG
    $TRTX
    Investment Managers
    Finance
    Real Estate Investment Trusts
    Real Estate

    $ABC
    $TPG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by TPG Inc.

    SC 13G - TPG Inc. (0001880661) (Subject)

    3/7/24 4:25:32 PM ET
    $TPG
    Investment Managers
    Finance

    SEC Form SC 13D/A filed by TPG Inc. (Amendment)

    SC 13D/A - TPG Inc. (0001880661) (Subject)

    3/4/24 4:16:38 PM ET
    $TPG
    Investment Managers
    Finance

    SEC Form SC 13D/A filed by TPG Inc. (Amendment)

    SC 13D/A - TPG Inc. (0001880661) (Subject)

    2/28/24 5:07:32 PM ET
    $TPG
    Investment Managers
    Finance

    $ABC
    $TPG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TPG Inc. upgraded by BNP Paribas Exane with a new price target

    BNP Paribas Exane upgraded TPG Inc. from Neutral to Outperform and set a new price target of $69.00

    7/30/25 7:19:36 AM ET
    $TPG
    Investment Managers
    Finance

    Wolfe Research initiated coverage on TPG Inc. with a new price target

    Wolfe Research initiated coverage of TPG Inc. with a rating of Outperform and set a new price target of $60.00

    6/20/25 7:55:00 AM ET
    $TPG
    Investment Managers
    Finance

    TPG Inc. downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded TPG Inc. from Overweight to Equal-Weight and set a new price target of $47.00

    4/14/25 8:15:24 AM ET
    $TPG
    Investment Managers
    Finance